Hideki Nakayama

4.2k total citations
158 papers, 3.0k citations indexed

About

Hideki Nakayama is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Hideki Nakayama has authored 158 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Oncology, 43 papers in Molecular Biology and 30 papers in Cancer Research. Recurrent topics in Hideki Nakayama's work include Head and Neck Cancer Studies (26 papers), Cancer-related molecular mechanisms research (13 papers) and Salivary Gland Tumors Diagnosis and Treatment (12 papers). Hideki Nakayama is often cited by papers focused on Head and Neck Cancer Studies (26 papers), Cancer-related molecular mechanisms research (13 papers) and Salivary Gland Tumors Diagnosis and Treatment (12 papers). Hideki Nakayama collaborates with scholars based in Japan, United States and Egypt. Hideki Nakayama's co-authors include Ryoji Yoshida, Masanori Shinohara, Masashi Nagata, Kenta Kawahara, Akiyuki Hirosue, Toshiro Hara, Tetsuro Ikebe, Kanemitsu Shirasuna, Akimitsu Hiraki and Shunji Hikino and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and Blood.

In The Last Decade

Hideki Nakayama

146 papers receiving 3.0k citations

Peers

Hideki Nakayama

ONCOL

IMMUN

SURGE

Bin Zhou China

Ying Jin China

Ming-Hsui Tsai Taiwan

Yun‐Shien Lee Taiwan

Jessica Wang‐Rodriguez United States

Nina Zidar Slovenia

L Chyczewski Poland

Francesco Perri Italy

Weiping Wen China

Bin Zhou China

Hideki Nakayama

995 ×0.9

470 ×0.5

ONCOL

430 ×0.7

582 ×0.9

IMMUN

389 ×0.9

SURGE

Citations per year, relative to Hideki Nakayama Hideki Nakayama (= 1×) peers Bin Zhou

Countries citing papers authored by Hideki Nakayama

Since Specialization

Citations

This map shows the geographic impact of Hideki Nakayama's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Nakayama with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Nakayama more than expected).

Fields of papers citing papers by Hideki Nakayama

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Nakayama. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Nakayama. The network helps show where Hideki Nakayama may publish in the future.

Co-authorship network of co-authors of Hideki Nakayama

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Nakayama. A scholar is included among the top collaborators of Hideki Nakayama based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Nakayama. Hideki Nakayama is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yano, Hiromu, Yoshihiro Komohara, Rin Yamada, et al.. (2025). Cytotoxic T Lymphocyte Density and PD‐L1 Expression Predict the Response to Anti‐PD1 Therapy in Recurrent Oral Squamous Cell Carcinoma. Microbiology and Immunology. 69(6). 350–358.

Kawakita, Daisuke, Seiichi Yoshimoto, Munenaga Nakamizo, et al.. (2025). Head and neck cancer registry of Japan. Auris Nasus Larynx. 52(2). 122–126. 1 indexed citations

Toya, Ryo, Tetsuo Saito, Tomohiko Matsuyama, et al.. (2024). Radiation Therapy Oncology Group 8502 “QUAD shot” regimen using volumetric modulated arc therapy for incurable head and neck cancer. Oral Oncology. 151. 106752–106752. 1 indexed citations

Nakayama, Hideki, et al.. (2024). Label Augmentation as Inter-class Data Augmentation for Conditional Image Synthesis with Imbalanced Data. 33. 4932–4941. 1 indexed citations

Huang, Hen‐Hsen, et al.. (2023). LED: A Dataset for Life Event Extraction from Dialogs. 384–398.

Okajima, Hiroshi, et al.. (2023). Ozone mediates the anticancer effect of air plasma by triggering oxidative cell death caused by H2O2 and iron. European Journal of Cell Biology. 102(4). 151346–151346. 4 indexed citations

Chen, Hong, et al.. (2022). StoryER: Automatic Story Evaluation via Ranking, Rating and Reasoning. 1739–1753. 1 indexed citations

Sakata, Junki, Akiyuki Hirosue, Ryoji Yoshida, et al.. (2020). Enhanced Expression of IGFBP-3 Reduces Radiosensitivity and Is Associated with Poor Prognosis in Oral Squamous Cell Carcinoma. Cancers. 12(2). 494–494. 8 indexed citations

Yoshida, Ryoji, Masashi Nagata, Akiyuki Hirosue, et al.. (2020). Efficacy of adjuvant chemotherapy with S-1 in stage II oral squamous cell carcinoma patients: A comparative study using the propensity score matching method. PLoS ONE. 15(4). e0231656–e0231656. 2 indexed citations

10.

Kawahara, Kenta, Akimitsu Hiraki, Hidetaka Arita, et al.. (2020). Role of serum amylase and salivary cytokines in oral complications during chemoradiotherapy. Oral Diseases. 27(6). 1564–1571. 5 indexed citations

11.

Sakata, Junki, Akiyuki Hirosue, Ryoji Yoshida, et al.. (2019). HMGA2 Contributes to Distant Metastasis and Poor Prognosis by Promoting Angiogenesis in Oral Squamous Cell Carcinoma. International Journal of Molecular Sciences. 20(10). 2473–2473. 34 indexed citations

12.

Okazaki, Shogo, Kiyoko Umene, Juntaro Yamasaki, et al.. (2019). Glutaminolysis‐related genes determine sensitivity to xCT‐targeted therapy in head and neck squamous cell carcinoma. Cancer Science. 110(11). 3453–3463. 62 indexed citations

13.

Abdalla, Mohamed O., Tatsuro Yamamoto, Kazumitsu Maehara, et al.. (2019). The Eleanor ncRNAs activate the topological domain of the ESR1 locus to balance against apoptosis. Nature Communications. 10(1). 3778–3778. 29 indexed citations

14.

Tsukamoto, Hirotake, Koji Fujieda, Masatoshi Hirayama, et al.. (2017). Soluble IL6R Expressed by Myeloid Cells Reduces Tumor-Specific Th1 Differentiation and Drives Tumor Progression. Cancer Research. 77(9). 2279–2291. 46 indexed citations

15.

Nakayama, Hideki & Susumu Higuchi. (2015). [Internet addiction].. PubMed. 73(9). 1559–66. 5 indexed citations

16.

Yoshitake, Yoshihiro, Daiki Fukuma, Akira Yuno, et al.. (2014). Phase II Clinical Trial of Multiple Peptide Vaccination for Advanced Head and Neck Cancer Patients Revealed Induction of Immune Responses and Improved OS. Clinical Cancer Research. 21(2). 312–321. 123 indexed citations

17.

Nakayama, Hideki, et al.. (2012). A case of descending necrotizing mediastinitis caused by post-extraction infection. Japanese Journal of Oral & Maxillofacial Surgery. 58(5). 332–336. 1 indexed citations

18.

Miyoshi, Miki, et al.. (2007). . 12(1). 27–34. 7 indexed citations

19.

Yamamoto, Junko, Kenji Ihara, Hideki Nakayama, et al.. (2003). Characteristic expression of aryl hydrocarbon receptor repressor gene in human tissues: Organ-specific distribution and variable induction patterns in mononuclear cells. Life Sciences. 74(8). 1039–1049. 90 indexed citations

20.

Jin, Cheng‐Hao, Hidetoshi Takada, Akihiko Nomura, et al.. (2000). Immunophenotypic and functional characterization of CD33+CD34+ cells in human cord blood of preterm neonates. Experimental Hematology. 28(10). 1174–1180. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact